According to Arm's initial public offering documents filed with the US SEC, the new deal extends beyond 2040 and will enable the British semiconductor firm to continue its longstanding relationship of collaboration with Apple and the iPhone maker’s access to the Arm architecture

1194px-Apple_store_fifth_avenue

Apple and Arm sign new long-term agreement that extends beyond 2040. (Credit: Ed Uthman, MD/Wikimedia Commons)

Apple has inked a new long-term agreement with UK-based semiconductor and software design company Arm for chip technology.

According to Arm’s initial public offering (IPO) documents filed with the US Securities and Exchange Commission (SEC), the new deal extends beyond 2040.

It will enable the British semiconductor firm to continue its longstanding relationship of collaboration with Apple and the latter’s access to the Arm architecture.

Arm also said that several technology companies have indicated an interest in purchasing up to an aggregate of $735m of the American depositary shares (ADSs) offered in the offering at the IPO price.

The companies include Advanced Micro Devices, MediaTek’s affiliated entities, Nvidia, Apple, Cadence Design Systems, Google International, Intel, Samsung Electronics, Synopsys, and TSMC Partners.

Headquartered in Cambridge, Arm offers processor IP technology and a broad range of processors, designed to meet the performance, power, and cost requirements of every device.

The company’s central processing units (CPUs) and neural processing units (NPUs) include Cortex-A, Cortex-R, Cortex-M, Neoverse, Ethos, and SecurCore.

According to Reuters, Apple uses Arm’s technology in the processes of designing its own custom chips for iPhones, Macs, and iPads.

Last month, Softbank Group was reported to have taken full ownership of Arm in a deal that values the latter at $64bn.

The Japanese company acquired the 25% interest in Arm that it did not already own from its Vision Fund unit.

In September 2020, Nvidia agreed to acquire Arm from SoftBank Group and Vision Fund in a cash and stock deal that was valued at $40bn. However, the deal was terminated by the parties in February 2022 due to significant regulatory obstacles.